Newron Pharmaceuticals Spa. (NP5.MU) Q1 2026 Earnings

24MarConfirmed
Q1 2026
-0.67
-0.63
-0.6
-0.57

Details

Expected EPS
-0.56617019648
Actual EPS
-0.66727201728
Surprise EPS
-0.1
Surprise Percent
+17.86%

Description

Newron Pharmaceuticals Spa. (NP5.MU) has reported earnings of -0.66727201728 per share for Q1 2026.

0 Comments

Share your thoughts